← Insider buys

Peter Anevski has bought PGNY on 2 days since Dec 2024

CEO at Progyny, Inc.

SEC CIK 0001576147 · Filings on SEC.gov ↗

$5.0MBought
$135.3MSold
Nov 17Last buy

Peter Anevski's record

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Every filing

69 filings since Oct 2019, newest first

PGNYBuy

Progyny, Inc.

CEO

$1.9M+13.0%Nov 17
PGNYBuy

Progyny, Inc.

CEO

$3.0M+90.0%Dec 26
PGNYSell

Progyny, Inc.

CEO

$782K−9.0%Jul 18
PGNYSell

Progyny, Inc.

CEO

$2.7M−25.0%Jul 14
PGNYSell

Progyny, Inc.

CEO

$312K−3.0%Jul 6
PGNYSell

Progyny, Inc.

CEO

$819K−8.0%Jun 8
PGNYSell

Progyny, Inc.

CEO

$1.6M−14.0%Jun 7
PGNYSell

Progyny, Inc.

CEO

$1.5M−14.0%Jun 5
PGNYSell

Progyny, Inc.

CEO

$289K−10.0%May 18
PGNYSell

Progyny, Inc.

CEO

$207K−2.0%May 18
PGNYSell

Progyny, Inc.

CEO

$2.9M−24.0%May 16
PGNYSell

Progyny, Inc.

CEO

$3.0M−23.0%May 12
PGNYSell

Progyny, Inc.

CEO

$2.5M−20.0%May 10
PGNYSell

Progyny, Inc.

CEO

$448K−4.0%Apr 25
PGNYSell

Progyny, Inc.

CEO

$46KMar 10
PGNYSell

Progyny, Inc.

CEO

$2.4M−18.0%Mar 8
PGNYSell

Progyny, Inc.

CEO

$2.9M−20.0%Mar 6
PGNYSell

Progyny, Inc.

CEO

$3.0M−19.0%Mar 2
PGNYSell

Progyny, Inc.

CEO

$102K−1.0%Feb 8
PGNYSell

Progyny, Inc.

CEO

$2.9M−18.0%Feb 6
PGNYSell

Progyny, Inc.

CEO

$1.4M−10.0%Feb 2
PGNYSell

Progyny, Inc.

CEO

$1.3M−7.0%Nov 9
PGNYSell

Progyny, Inc.

CEO

$1.1M−6.0%Nov 7
PGNYSell

Progyny, Inc.

CEO

$1.7M−9.0%Nov 3
PGNYSell

Progyny, Inc.

CEO

$1.8M−10.0%Oct 27
PGNYSell

Progyny, Inc.

CEO

$111K−1.0%Oct 24
PGNYSell

Progyny, Inc.

CEO

$911K−5.0%Oct 19
PGNYSell

Progyny, Inc.

CEO

$118K−1.0%Oct 17
PGNYSell

Progyny, Inc.

CEO

$1.1M−6.0%Oct 7
PGNYSell

Progyny, Inc.

CEO

$205K−1.0%Sep 12
PGNYSell

Progyny, Inc.

CEO

$3.0M−14.0%Sep 9
PGNYSell

Progyny, Inc.

CEO

$787K−4.0%Sep 6
PGNYSell

Progyny, Inc.

CEO

$898K−4.0%Aug 16
PGNYSell

Progyny, Inc.

CEO

$1.8M−8.0%Aug 12
PGNYSell

Progyny, Inc.

CEO

$1.7M−8.0%Aug 10
PGNYSell

Progyny, Inc.

CEO

$915K−4.0%Mar 8
PGNYSell

Progyny, Inc.

CEO

$1.8M−8.0%Mar 4
PGNYSell

Progyny, Inc.

CEO

$5.8M−21.0%Mar 2
PGNYSell

Progyny, Inc.

CEO

$25KMar 2
PGNYSell

Progyny, Inc.

CEO

$830K−3.0%Feb 17
PGNYSell

Progyny, Inc.

CEO

$1.1M−3.0%Jan 5
PGNYSell

Progyny, Inc.

President and COO

$2.4M−8.0%Oct 8
PGNYSell

Progyny, Inc.

President and COO

$4.7M−14.0%Oct 5
PGNYSell

Progyny, Inc.

President and COO

$5.5M−17.0%Oct 1
PGNYSell

Progyny, Inc.

President and COO

$6.5M−18.0%Sep 29
PGNYSell

Progyny, Inc.

President and COO

$4.3M−15.0%Aug 27
PGNYSell

Progyny, Inc.

President and COO

$150K−5.0%Jun 22
PGNYSell

Progyny, Inc.

President and COO

$2.5M−7.0%Jun 3
PGNYSell

Progyny, Inc.

President and COO

$2.2M−7.0%May 7
PGNYSell

Progyny, Inc.

President and COO

$2.3M−6.0%May 5
About Peter Anevski

Peter Anevski is the Chief Executive Officer and a director of Progyny, Inc. (PGNY) since January 2022, having previously served as the company's Chief Operating Officer (2017–2021), President (2019–2021), and Chief Financial Officer (2017–2020).( Prior to joining Progyny, he held the role of Executive Vice President and CFO at WebMD from 2013 to 2016, following 14 years in senior finance and operations positions at WebMD and its predecessors.( He holds a B.A. in Accounting from Montclair State University and is a member of the New Jersey State Society of Certified Public Accountants and the American Institute of Certified Public Accountants.(

Under Anevski's leadership, Progyny achieved record revenue of $1.167 billion in 2024 (+7.2% YoY) and expanded services into pregnancy, postpartum, and menopause care, serving over 1.5 million lives with high Net Promoter Scores (+79 fertility, +84 Rx).( He brings over two decades of experience scaling operations in healthcare, is a recipient of Ernst & Young's Entrepreneur of the Year 2024 New York Award, and Progyny was named to TIME 100's Most Influential Companies list for 2024.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.